Effect of Physical Therapy Exercise Program and Low-Level Laser Therapy on the Treatment of Cervicogenic Somatosensory Tinnitus
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04641156 |
|
Recruitment Status :
Completed
First Posted : November 23, 2020
Last Update Posted : February 1, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Tinnitus, Subjective | Other: Exercise Therapy program added to laser therapy | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effect of Adding Supervised Physical Therapy Exercise Program to Photobiomodulation Therapy in the Treatment of Cervicogenic Somatosensory Tinnitus: A Randomized Controlled Study |
| Actual Study Start Date : | December 10, 2018 |
| Actual Primary Completion Date : | March 5, 2019 |
| Actual Study Completion Date : | April 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Low level LASER Therapy
Subjects in this group received low-level laser therapy
|
Other: Exercise Therapy program added to laser therapy
a supervised physical therapy exercise program for the neck muscles in the form of manual mobilizations for sternocleidomastoid muscle and upper fibers of trapezius in addition to myofascial trigger point release |
|
Experimental: Exercise group
Subjects in this group received additional planned exercise therapy program
|
Other: Exercise Therapy program added to laser therapy
a supervised physical therapy exercise program for the neck muscles in the form of manual mobilizations for sternocleidomastoid muscle and upper fibers of trapezius in addition to myofascial trigger point release |
- VAS [ Time Frame: 8 weeks ]Numerical estimates of tinnitus severity before and after treatment for both groups
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 45 Years to 55 Years (Adult) |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age ranged from 45 to 55 years old both sex
- Unilateral tinnitus
- Stable tinnitus for at least 3 months
- suffering from severe chronic non-fluctuating subjective cervicogenic somatic tinnitus (CST)
Exclusion Criteria:
- tinnitus with clear ontological etiologies as perforation of the tympanic membrane
- external otitis media
- conductive hearing loss
- patients with a traumatic cervical spine injury, tumors
- Any history of exposure to ototoxic drugs/substances
- psychotic disorders with auditory hallucination
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04641156
| Egypt | |
| Marwa Eid | |
| Cairo, Egypt, 2011 | |
| Responsible Party: | Marwa Eid, Professor of physical therapy for surgery, Cairo University |
| ClinicalTrials.gov Identifier: | NCT04641156 |
| Other Study ID Numbers: |
6688 |
| First Posted: | November 23, 2020 Key Record Dates |
| Last Update Posted: | February 1, 2022 |
| Last Verified: | January 2022 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Tinnitus Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases |
Sensation Disorders Neurologic Manifestations Nervous System Diseases |

